RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

FHS
May 15, 2024
7:06 pm

A protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and mutations in the RPGRIP1L gene have been linked to different diseases.

Clearmind Medicine Announces Clinical Research Collaboration with Johns Hopkins University to Evaluate CMND-100 in Patients with Alcohol Use Disorder – Psychedelic Alpha

Tel Aviv, Israel / Vancouver, Canada, Sept. 06, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a

September 6, 2023

177Lu-PNT6555 by POINT Biopharma Global for Soft Tissue Sarcoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 26, 2023

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement | Psychedelic Invest

Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL / NASDAQ: IXHL), is pleased to provide its quarterly activities report and appendix 4C for

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.